226 related articles for article (PubMed ID: 30902828)
21. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
Meng Y; Yu CH; Li W; Li T; Luo W; Huang S; Wu PS; Cai SX; Li X
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):723-36. PubMed ID: 24168260
[TBL] [Abstract][Full Text] [Related]
22. Gelsolin expression is necessary for the development of modelled pulmonary inflammation and fibrosis.
Oikonomou N; Thanasopoulou A; Tzouvelekis A; Harokopos V; Paparountas T; Nikitopoulou I; Witke W; Karameris A; Kotanidou A; Bouros D; Aidinis V
Thorax; 2009 Jun; 64(6):467-75. PubMed ID: 19213772
[TBL] [Abstract][Full Text] [Related]
23. Highly Selective Endothelin-1 Receptor A Inhibition Prevents Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice.
Manitsopoulos N; Nikitopoulou I; Maniatis NA; Magkou C; Kotanidou A; Orfanos SE
Respiration; 2018; 95(2):122-136. PubMed ID: 29131071
[TBL] [Abstract][Full Text] [Related]
24. Phosphoinositide 3-kinase γ plays a critical role in bleomycin-induced pulmonary inflammation and fibrosis in mice.
Russo RC; Garcia CC; Barcelos LS; Rachid MA; Guabiraba R; Roffê E; Souza AL; Sousa LP; Mirolo M; Doni A; Cassali GD; Pinho V; Locati M; Teixeira MM
J Leukoc Biol; 2011 Feb; 89(2):269-82. PubMed ID: 21048214
[TBL] [Abstract][Full Text] [Related]
25. The role of high mobility group box1 in pulmonary fibrosis.
Hamada N; Maeyama T; Kawaguchi T; Yoshimi M; Fukumoto J; Yamada M; Yamada S; Kuwano K; Nakanishi Y
Am J Respir Cell Mol Biol; 2008 Oct; 39(4):440-7. PubMed ID: 18441281
[TBL] [Abstract][Full Text] [Related]
26. Induced pluripotent stem cells mediate the release of interferon gamma-induced protein 10 and alleviate bleomycin-induced lung inflammation and fibrosis.
How CK; Chien Y; Yang KY; Shih HC; Juan CC; Yang YP; Chiou GY; Huang PI; Chang YL; Chen LK; Wang CY; Hsu HS; Chiou SH; Lee CH
Shock; 2013 Mar; 39(3):261-70. PubMed ID: 23364435
[TBL] [Abstract][Full Text] [Related]
27. [Blocking IL-17A protects against lung injury-induced pulmonary fibrosis through promoting the activation of p50NF-kappaB].
Mi S; Li Z; Liu H; Hu ZW; Hua F
Yao Xue Xue Bao; 2012 Jun; 47(6):739-44. PubMed ID: 22919721
[TBL] [Abstract][Full Text] [Related]
28. Phenylbutyric acid inhibits epithelial-mesenchymal transition during bleomycin-induced lung fibrosis.
Zhao H; Qin HY; Cao LF; Chen YH; Tan ZX; Zhang C; Xu DX
Toxicol Lett; 2015 Jan; 232(1):213-20. PubMed ID: 25455454
[TBL] [Abstract][Full Text] [Related]
29. Interferon-γ stimulates p11-dependent surface expression of annexin A2 in lung epithelial cells to enhance phagocytosis.
Fang YT; Lin CF; Wang CY; Anderson R; Lin YS
J Cell Physiol; 2012 Jun; 227(6):2775-87. PubMed ID: 21928315
[TBL] [Abstract][Full Text] [Related]
30. IL-35 subunit EBI3 alleviates bleomycin-induced pulmonary fibrosis via suppressing DNA enrichment of STAT3.
Chen D; Zheng G; Yang Q; Luo L; Shen J
Respir Res; 2021 Oct; 22(1):280. PubMed ID: 34711217
[TBL] [Abstract][Full Text] [Related]
31. Annexin A2 regulates
Zhang H; Lu D; Zhang Y; Zhao G; Raheem A; Chen Y; Chen X; Hu C; Chen H; Yang L; Guo A
Front Immunol; 2022; 13():974006. PubMed ID: 36159852
[No Abstract] [Full Text] [Related]
32. Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis.
Damazo AS; Sampaio AL; Nakata CM; Flower RJ; Perretti M; Oliani SM
BMC Immunol; 2011 Oct; 12():59. PubMed ID: 22011168
[TBL] [Abstract][Full Text] [Related]
33. Iguratimod ameliorates bleomycin-induced alveolar inflammation and pulmonary fibrosis in mice by suppressing expression of matrix metalloproteinase-9.
Zhao L; Mu B; Zhou R; Cheng Y; Huang C
Int J Rheum Dis; 2019 Apr; 22(4):686-694. PubMed ID: 30666825
[TBL] [Abstract][Full Text] [Related]
34. Surfactant protein D attenuates sub-epithelial fibrosis in allergic airways disease through TGF-β.
Ogawa H; Ledford JG; Mukherjee S; Aono Y; Nishioka Y; Lee JJ; Izumi K; Hollingsworth JW
Respir Res; 2014 Nov; 15(1):143. PubMed ID: 25472740
[TBL] [Abstract][Full Text] [Related]
35. Attenuation of lung inflammation and fibrosis in interferon-gamma-deficient mice after intratracheal bleomycin.
Chen ES; Greenlee BM; Wills-Karp M; Moller DR
Am J Respir Cell Mol Biol; 2001 May; 24(5):545-55. PubMed ID: 11350823
[TBL] [Abstract][Full Text] [Related]
36. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways.
Ma WH; Li M; Ma HF; Li W; Liu L; Yin Y; Zhou XM; Hou G
Life Sci; 2020 Jan; 241():117139. PubMed ID: 31809714
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA H19 deficiency ameliorates bleomycin-induced pulmonary inflammation and fibrosis.
Wan X; Tian X; Du J; Lu Y; Xiao Y
Respir Res; 2020 Nov; 21(1):290. PubMed ID: 33138822
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of ANXA2 regulated by SRF attenuates the development of severe acute pancreatitis by inhibiting the NF-κB signaling pathway.
Tang G; Yu C; Xiang K; Gao M; Liu Z; Yang B; Yang M; Zhao S
Inflamm Res; 2022 Sep; 71(9):1067-1078. PubMed ID: 35900381
[TBL] [Abstract][Full Text] [Related]
39. Prostacyclin agonist with thromboxane synthase inhibitory activity (ONO-1301) attenuates bleomycin-induced pulmonary fibrosis in mice.
Murakami S; Nagaya N; Itoh T; Kataoka M; Iwase T; Horio T; Miyahara Y; Sakai Y; Kangawa K; Kimura H
Am J Physiol Lung Cell Mol Physiol; 2006 Jan; 290(1):L59-65. PubMed ID: 16155090
[TBL] [Abstract][Full Text] [Related]
40. Enhanced endogenous bone morphogenetic protein signaling protects against bleomycin induced pulmonary fibrosis.
De Langhe E; Cailotto F; De Vooght V; Aznar-Lopez C; Vanoirbeek JA; Luyten FP; Lories RJ
Respir Res; 2015 Mar; 16(1):38. PubMed ID: 25849157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
